|Project Title||Cutaneous Small-Vessel Vasculitis following Non-Vitamin K Antagonist Oral Anticoagulants (NOACs), Warfarin, or Allopurinol Use in Patients with Atrial Fibrillation: A Descriptive Analysis|
Monday, September 14, 2020
The purpose of this request was to calculate the number of treated patients and time to treatment among patients exposed to either non‐vitamin K antagonist oral anticoagulants (NOACs), warfarin, or allopurinol who had a prior diagnosis of atrial fibrillation in the Sentinel Distributed Database (SDD). The outcomes of interest were cutaneous small‐vessel vasculitis (CSVV) followed by a treatment of prednisone or prednisolone or steroid medication within 90 days.
The study period included data from October 19, 2010 to December 31, 2018. We distributed this request to 17 Data Partners on February 10, 2020.
non-vitamin K antagonist oral anticoagulants
cutaneous small vessel vasculitis
|Population / Cohort|
Individuals 21 years of age and older
October 19, 2010 - December 31, 2018
Sentinel Distributed Database (SDD)